ABL DIAGNOSTICS (EPA:ABLD) | WebDisclosure

Basculer en Français

11083	Companies
243258	Keywords
171440	Articles
131005	Press releases

Home
Companies
ABL DIAGNOSTICS

PRESS RELEASE

published on 06/12/2026 at 08:00, 3 months 13 days ago

Informations privilégiées / Autres communiqués
ABL Diagnostics et CDL Pharma remportent un contrat international pluriannuel de 2,7 M€ jusqu'en 2031 avec un laboratoire pharmaceutique européen, renforçant ainsi leurs activités dans les services à valeur ajoutée liés à la recherche clinique internationale

Recherche Clinique Maladies Neurodégénératives Contrat International ABL Diagnostics CDL Pharma
PRESS RELEASE

published on 06/12/2026 at 08:00, 3 months 13 days ago

Inside Information / Other news releases
ABL Diagnostics and CDL Pharma secure a multi-year international contract of up to €2.7 million through 2031. The contract involves services for neurodegenerative disease clinical programs across North America, Europe, and Asia

Neurodegenerative Diseases ABL Diagnostics Multi-year Contract CDL Pharma International Clinical Program
BRIEF

published on 06/10/2026 at 00:05, 3 months 15 days ago

ABL Diagnostics : Informations sur les droits de vote et le capital

Euronext Paris Droits De Vote Actions Nominatives Biologie Moléculaire Capital Social ABL
BRIEF

published on 06/10/2026 at 00:05, 3 months 15 days ago

ABL Diagnostics Discloses Voting and Share Information

Euronext Paris Share Capital Voting Rights Molecular Biology Double Voting
BRIEF

published on 06/10/2026 at 00:05, 3 months 15 days ago

ABL Diagnostics: Information on voting rights and capital

Euronext Paris Voting Rights Registered Shares Molecular Biology ABL Share Capital
BRIEF

published on 06/10/2026 at 00:05, 3 months 15 days ago

ABL Diagnostics divulgue des informations sur le vote et les actions

Euronext Paris Capital Social Droit De Vote Biologie Moléculaire Double Vote
PRESS RELEASE

published on 06/10/2026 at 00:00, 3 months 15 days ago

Modalités de mise à disposition des documents préparatoires à l'AG
ABL Diagnostics (ABLD) est une société internationale spécialisée dans les tests de biologie moléculaire innovants. Son siège est à Woippy. Elle est cotée sur Euronext Paris

Euronext Paris Biologie Moléculaire ABL Diagnostics Innovants Woippy
PRESS RELEASE

published on 06/10/2026 at 00:00, 3 months 15 days ago

Terms of availability of the preparatory documents for the GM
ABL Diagnostics (ABLD) discloses information on total voting rights and share capital composition as per regulatory requirements. The company specializes in molecular biology tests and global solutions for academic labs, private labs, and researchers

Share Capital Voting Rights Regulatory Disclosure ABL Diagnostics Molecular Biology Tests
BRIEF

published on 06/09/2026 at 19:05, 3 months 16 days ago

ABL Diagnostics prépare son Assemblée Générale du 30 juin 2026

Assemblée Générale Investisseurs Documents Préparatoires Biologie Moléculaire ABL Diagnostics
BRIEF

published on 06/09/2026 at 19:05, 3 months 16 days ago

ABL Diagnostics Announces General Meeting on June 30, 2026

Shareholders Financial Statements Paris General Meeting ABL Diagnostics

Accesswire

Published on 09/25/2026 at 17:30, 4 hours ago

Goldcliff Announces Unit and Flow Through "LIFE" Offerings
Published on 09/25/2026 at 15:00, 6 hours 30 minutes ago

HM Exploration Provides Program Update for the Lewis Pilley's Project
Published on 09/25/2026 at 14:00, 7 hours 30 minutes ago

Karbon-X (OTCQB:KARX) to Present Global Growth Strategy and Showcase SkyXero at 26th MK-Equity Investment Conference in Munich
Published on 09/25/2026 at 13:00, 8 hours 30 minutes ago

Core Silver Announces Grant of Stock Options
Published on 09/25/2026 at 13:00, 8 hours 30 minutes ago

American Hotel Income Properties REIT LP Announces Corporate Update

View all ACCESSWIRE

EQS Group

Published on 09/25/2026 at 18:30, 3 hours ago

029 Group SE: Publication of Half-Year Report 2026
Published on 09/25/2026 at 18:15, 3 hours 15 minutes ago

Warren Wise decodes Qiagen’s DNA
Published on 09/25/2026 at 18:00, 3 hours 30 minutes ago

ABIVAX: Nombre d’actions composant le capital social et nombre total de droits de vote au 31.08.26
Published on 09/25/2026 at 17:30, 4 hours ago

GEVELOT S.A.: Weekly declaration of share buybacks – 09/25/2026 (French only)
Published on 09/25/2026 at 17:30, 4 hours ago

GEVELOT S.A.: Déclaration hebdomadaire de rachat d'actions 25/09/2026

Les Echos

Published on 09/25/2026 at 18:00, 3 hours 30 minutes ago

COGRA : RAPPORT FINANCIER ANNUEL 2025/26
Published on 09/25/2026 at 18:00, 3 hours 30 minutes ago

COGRA : RAPPORT FINANCIER ANNUEL 2025/26
Published on 09/25/2026 at 17:45, 3 hours 45 minutes ago

COGRA : ASSEMBLÉE GÉNÉRALE MIXTE DU 16 OCTOBRE 2026 / MISE À DISPOSITION DU RAPPORT FINANCIER ANNUEL 2025/2026
Published on 09/25/2026 at 17:40, 3 hours 50 minutes ago

Availability of the 2026 half-year financial report
Published on 09/25/2026 at 17:40, 3 hours 50 minutes ago

Mise à disposition du rapport financier semestriel 2026

View all LES ECHOS COMFI WIRE